{"id": "article-43010_0", "title": "Vasodilators -- Continuing Education Activity", "content": "Vasodilators are useful in the management of hypertension, angina, heart failure, myocardial infarction, and more. This activity reviews the indications, actions, and contraindications for vasodilation therapy as a valuable agent in the treatment of hypertension and other related disorders. This activity will also highlight the mechanism of action, adverse event profile, and other key factors pertinent to members of the interprofessional team in the treatment of patients with hypertension and related conditions.", "contents": "Vasodilators -- Continuing Education Activity. Vasodilators are useful in the management of hypertension, angina, heart failure, myocardial infarction, and more. This activity reviews the indications, actions, and contraindications for vasodilation therapy as a valuable agent in the treatment of hypertension and other related disorders. This activity will also highlight the mechanism of action, adverse event profile, and other key factors pertinent to members of the interprofessional team in the treatment of patients with hypertension and related conditions."}
{"id": "article-43010_1", "title": "Vasodilators -- Continuing Education Activity", "content": "Objectives: Describe the pathophysiology of vasoconstriction. Review the adverse side effects of vasodilator therapy. Outline the indications of vasodilator therapy. Summarize some interprofessional team strategies for improving care coordination and communication to advance vasodilator use and improve outcomes. Access free multiple choice questions on this topic.", "contents": "Vasodilators -- Continuing Education Activity. Objectives: Describe the pathophysiology of vasoconstriction. Review the adverse side effects of vasodilator therapy. Outline the indications of vasodilator therapy. Summarize some interprofessional team strategies for improving care coordination and communication to advance vasodilator use and improve outcomes. Access free multiple choice questions on this topic."}
{"id": "article-43010_2", "title": "Vasodilators -- Indications", "content": "Vasodilators are useful in treating a variety of medical conditions, most commonly systemic hypertension. [1] Other diseases include myocardial infarction (both ST-segment elevation and non-ST-segment\u00a0elevation), angina, heart failure, stroke, chronic kidney disease, preeclampsia, hypertensive emergency.\u00a0There are different\u00a0classes of vasodilators used today in the current clinical practice, and each has different actions on the coronary arteries and peripheral\u00a0vasculature (arteries and veins).\u00a0Vasodilators most commonly affect the arteries in the human body, but some vasodilators (such as nitroglycerin) can affect the venous system of the body predominantly. Several different vasodilators have undergone development over the years, as mentioned below. [2]", "contents": "Vasodilators -- Indications. Vasodilators are useful in treating a variety of medical conditions, most commonly systemic hypertension. [1] Other diseases include myocardial infarction (both ST-segment elevation and non-ST-segment\u00a0elevation), angina, heart failure, stroke, chronic kidney disease, preeclampsia, hypertensive emergency.\u00a0There are different\u00a0classes of vasodilators used today in the current clinical practice, and each has different actions on the coronary arteries and peripheral\u00a0vasculature (arteries and veins).\u00a0Vasodilators most commonly affect the arteries in the human body, but some vasodilators (such as nitroglycerin) can affect the venous system of the body predominantly. Several different vasodilators have undergone development over the years, as mentioned below. [2]"}
{"id": "article-43010_3", "title": "Vasodilators -- Indications", "content": "Direct-acting vasodilators (hydralazine, minoxidil, nitrates, nitroprusside) Calcium channel blockers (verapamil, diltiazem, nifedipine, amlodipine) An antagonist of the renin-angiotensin-aldosterone system (angiotensin receptor blockers, angiotensin-converting-enzyme inhibitors) Beta-2 receptor agonist (salbutamol, terbutaline) Postsynaptic alpha-1 receptor antagonist (prazosin, phenoxybenzamine, phentolamine) Centrally acting alpha-2 receptor agonist (clonidine,\u00a0\u03b1-methyldopa) Endothelin receptor antagonist (bosentan, ambrisentan) Phosphodiesterase inhibitors (sildenafil, tadalafil)", "contents": "Vasodilators -- Indications. Direct-acting vasodilators (hydralazine, minoxidil, nitrates, nitroprusside) Calcium channel blockers (verapamil, diltiazem, nifedipine, amlodipine) An antagonist of the renin-angiotensin-aldosterone system (angiotensin receptor blockers, angiotensin-converting-enzyme inhibitors) Beta-2 receptor agonist (salbutamol, terbutaline) Postsynaptic alpha-1 receptor antagonist (prazosin, phenoxybenzamine, phentolamine) Centrally acting alpha-2 receptor agonist (clonidine,\u00a0\u03b1-methyldopa) Endothelin receptor antagonist (bosentan, ambrisentan) Phosphodiesterase inhibitors (sildenafil, tadalafil)"}
{"id": "article-43010_4", "title": "Vasodilators -- Indications", "content": "Renin-angiotensin-aldosterone system blockers such as ACE inhibitors and ARBs are first-line of the treatment in patients with heart failure, history of ST-elevation myocardial infarction, diabetes, or proteinuria. Both groups of medications have cardioprotective and renoprotective effects.", "contents": "Vasodilators -- Indications. Renin-angiotensin-aldosterone system blockers such as ACE inhibitors and ARBs are first-line of the treatment in patients with heart failure, history of ST-elevation myocardial infarction, diabetes, or proteinuria. Both groups of medications have cardioprotective and renoprotective effects."}
{"id": "article-43010_5", "title": "Vasodilators -- Indications", "content": "Clinicians can use many vasodilators in preeclampsia, which is a condition seen in the pregnancy characterized by severe hypertension and proteinuria.\u00a0If not treated quickly, patients can develop seizures. ACE Inhibitors and ARBs are contraindicated in pregnancy due to teratogenicity. Hydralazine and calcium channel blockers (amlodipine, nifedipine) are safe to use in these circumstances.", "contents": "Vasodilators -- Indications. Clinicians can use many vasodilators in preeclampsia, which is a condition seen in the pregnancy characterized by severe hypertension and proteinuria.\u00a0If not treated quickly, patients can develop seizures. ACE Inhibitors and ARBs are contraindicated in pregnancy due to teratogenicity. Hydralazine and calcium channel blockers (amlodipine, nifedipine) are safe to use in these circumstances."}
{"id": "article-43010_6", "title": "Vasodilators -- Indications", "content": "Many vasodilators are used in hypertensive emergencies and urgencies. Hypertensive emergency is defined as an elevation of systolic blood pressure over 180 mmHg and/or diastolic blood pressure exceeding 120 mmHg with the presence of acute target organ damage (such as kidney insult, encephalopathy, retinal hemorrhage, aortic dissection, subarachnoid hemorrhage). Hypertensive urgencies are defined as an elevation of systolic blood pressure greater than 180 mmHg and/or diastolic blood pressure over 120 mmHg without any clinical or laboratory evidence of acute\u00a0end-organ damage.\u00a0In hypertensive emergency following drugs are the first choice depending on systemic involvement.", "contents": "Vasodilators -- Indications. Many vasodilators are used in hypertensive emergencies and urgencies. Hypertensive emergency is defined as an elevation of systolic blood pressure over 180 mmHg and/or diastolic blood pressure exceeding 120 mmHg with the presence of acute target organ damage (such as kidney insult, encephalopathy, retinal hemorrhage, aortic dissection, subarachnoid hemorrhage). Hypertensive urgencies are defined as an elevation of systolic blood pressure greater than 180 mmHg and/or diastolic blood pressure over 120 mmHg without any clinical or laboratory evidence of acute\u00a0end-organ damage.\u00a0In hypertensive emergency following drugs are the first choice depending on systemic involvement."}
{"id": "article-43010_7", "title": "Vasodilators -- Indications", "content": "Aortic dissection: intravenous esmolol, intravenous nitroprusside, or nitroglycerine Acute pulmonary edema:\u00a0intravenous\u00a0nitroglycerine, nitroprusside, or clevidipine Acute myocardial infarction/unstable angina:\u00a0intravenous esmolol or\u00a0nitroglycerine Acute renal failure:\u00a0intravenous fenoldopam, clevidipine, or nicardipine Eclampsia: intravenous hydralazine, nicardipine, or labetalol Pheochromocytoma/hyperadrenergic state secondary to amphetamine or cocaine:\u00a0intravenous clevidipine, phentolamine, or nicardipine", "contents": "Vasodilators -- Indications. Aortic dissection: intravenous esmolol, intravenous nitroprusside, or nitroglycerine Acute pulmonary edema:\u00a0intravenous\u00a0nitroglycerine, nitroprusside, or clevidipine Acute myocardial infarction/unstable angina:\u00a0intravenous esmolol or\u00a0nitroglycerine Acute renal failure:\u00a0intravenous fenoldopam, clevidipine, or nicardipine Eclampsia: intravenous hydralazine, nicardipine, or labetalol Pheochromocytoma/hyperadrenergic state secondary to amphetamine or cocaine:\u00a0intravenous clevidipine, phentolamine, or nicardipine"}
{"id": "article-43010_8", "title": "Vasodilators -- Indications", "content": "This review\u00a0will focus more on direct-acting vasodilators, calcium channel blockers, and renin-angiotensin-aldosterone antagonists\u00a0as these classes of medications are more commonly used in the current practice.", "contents": "Vasodilators -- Indications. This review\u00a0will focus more on direct-acting vasodilators, calcium channel blockers, and renin-angiotensin-aldosterone antagonists\u00a0as these classes of medications are more commonly used in the current practice."}
{"id": "article-43010_9", "title": "Vasodilators -- Mechanism of Action", "content": "In general, Vasodilators dilate or prevent constriction of the blood vessels,\u00a0which\u00a0allow greater blood flow to various organs in\u00a0the body. [3] Many vasodilators bind to receptors on endothelial cells of the blood vessel, which stimulate calcium release. Calcium activates the enzyme nitric oxide synthase (NO synthase) and converts L-arginine into NO. It leaves the endothelial cell\u00a0via diffusion and enters vascular smooth muscle cells. NO activates GTP and converts it into cGMP. cGMP then stimulates myosin-light chain phosphatase, which removes a single phosphate from myosin and actin filaments. The dephosphorylation of myosin and actin filaments allows vascular smooth muscle relaxation. Below are the specific mechanisms of action for\u00a0different\u00a0classes of vasodilators: ACE Inhibitors: Prevent the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. [4] Angiotensin Receptor Blockers : Prevent\u00a0angiotensin II from binding to its receptor.", "contents": "Vasodilators -- Mechanism of Action. In general, Vasodilators dilate or prevent constriction of the blood vessels,\u00a0which\u00a0allow greater blood flow to various organs in\u00a0the body. [3] Many vasodilators bind to receptors on endothelial cells of the blood vessel, which stimulate calcium release. Calcium activates the enzyme nitric oxide synthase (NO synthase) and converts L-arginine into NO. It leaves the endothelial cell\u00a0via diffusion and enters vascular smooth muscle cells. NO activates GTP and converts it into cGMP. cGMP then stimulates myosin-light chain phosphatase, which removes a single phosphate from myosin and actin filaments. The dephosphorylation of myosin and actin filaments allows vascular smooth muscle relaxation. Below are the specific mechanisms of action for\u00a0different\u00a0classes of vasodilators: ACE Inhibitors: Prevent the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. [4] Angiotensin Receptor Blockers : Prevent\u00a0angiotensin II from binding to its receptor."}
{"id": "article-43010_10", "title": "Vasodilators -- Mechanism of Action", "content": "Nitrates: Increase the amount of NO in vascular smooth muscle cells, causing vasodilation. Nitrates dilate veins more than arteries and decrease preload.", "contents": "Vasodilators -- Mechanism of Action. Nitrates: Increase the amount of NO in vascular smooth muscle cells, causing vasodilation. Nitrates dilate veins more than arteries and decrease preload."}
{"id": "article-43010_11", "title": "Vasodilators -- Mechanism of Action", "content": "Calcium Channel Blockers: Block calcium channels in the cardiac and smooth muscles, causing decreased muscle contractility and vasodilation. There are two classes of CCBs: Dihydropyridines (act on the vascular smooth muscle), and non-dihydropyridines (act on the heart). Minoxidil: Directly relaxes arteriolar smooth muscle, with minimal effect on the vein. Cyclic AMP may mediate its effects. Hydralazine: the exact mechanism is still unknown. Beta-Blockers: Nebivolol and carvedilol are third-generation \u03b2-adrenoreceptor antagonists that have additional endothelium-dependent vasodilating properties.", "contents": "Vasodilators -- Mechanism of Action. Calcium Channel Blockers: Block calcium channels in the cardiac and smooth muscles, causing decreased muscle contractility and vasodilation. There are two classes of CCBs: Dihydropyridines (act on the vascular smooth muscle), and non-dihydropyridines (act on the heart). Minoxidil: Directly relaxes arteriolar smooth muscle, with minimal effect on the vein. Cyclic AMP may mediate its effects. Hydralazine: the exact mechanism is still unknown. Beta-Blockers: Nebivolol and carvedilol are third-generation \u03b2-adrenoreceptor antagonists that have additional endothelium-dependent vasodilating properties."}
{"id": "article-43010_12", "title": "Vasodilators -- Administration", "content": "Vasodilators can be\u00a0administered in a variety of ways, including sublingual, IV, oral. [5]", "contents": "Vasodilators -- Administration. Vasodilators can be\u00a0administered in a variety of ways, including sublingual, IV, oral. [5]"}
{"id": "article-43010_13", "title": "Vasodilators -- Administration", "content": "Depending on the clinical setting, some routes of administration can be more beneficial than others. For example, in the setting of acute myocardial infarction (MI), patients\u00a0will more\u00a0likely benefit from sublingual nitroglycerin, as it is absorbed much faster\u00a0by the sublingual route and allows the patient to feel more comfortable and often reduces the chest pain. [6] Whereas for\u00a0the\u00a0patients who need to reduce their blood pressure in a non-emergent manner, the oral route is an acceptable route of administration.", "contents": "Vasodilators -- Administration. Depending on the clinical setting, some routes of administration can be more beneficial than others. For example, in the setting of acute myocardial infarction (MI), patients\u00a0will more\u00a0likely benefit from sublingual nitroglycerin, as it is absorbed much faster\u00a0by the sublingual route and allows the patient to feel more comfortable and often reduces the chest pain. [6] Whereas for\u00a0the\u00a0patients who need to reduce their blood pressure in a non-emergent manner, the oral route is an acceptable route of administration."}
{"id": "article-43010_14", "title": "Vasodilators -- Administration", "content": "Nitrovasodilators such as nitroprusside and nitroglycerin are frequently used in hypertensive emergencies. Sodium nitroprusside administration is via the intravenous route in such conditions. It\u00a0starts blood pressure-lowering action within\u00a0one minute or less, and these effects disappear within 10 minutes after discontinuation. Frequent clinical monitoring is necessary\u00a0during the administration of this medication.", "contents": "Vasodilators -- Administration. Nitrovasodilators such as nitroprusside and nitroglycerin are frequently used in hypertensive emergencies. Sodium nitroprusside administration is via the intravenous route in such conditions. It\u00a0starts blood pressure-lowering action within\u00a0one minute or less, and these effects disappear within 10 minutes after discontinuation. Frequent clinical monitoring is necessary\u00a0during the administration of this medication."}
{"id": "article-43010_15", "title": "Vasodilators -- Administration", "content": "Similar to nitroprusside, nitroglycerin can be used intravenously in certain conditions. It has very similar kinetic, but it produces greater venodilation compared to arteriolar dilation. Extended used is generally avoided due to concerns of tachyphylaxis. Severe hypertension\u00a0during labor should be treated with intravenous labetalol/hydralazine or oral nifedipine to prevent intracranial hemorrhage or eclampsia.", "contents": "Vasodilators -- Administration. Similar to nitroprusside, nitroglycerin can be used intravenously in certain conditions. It has very similar kinetic, but it produces greater venodilation compared to arteriolar dilation. Extended used is generally avoided due to concerns of tachyphylaxis. Severe hypertension\u00a0during labor should be treated with intravenous labetalol/hydralazine or oral nifedipine to prevent intracranial hemorrhage or eclampsia."}
{"id": "article-43010_16", "title": "Vasodilators -- Administration", "content": "Calcium channel blockers such as clevidipine and nicardipine can be used intravenously in hypertensive emergencies while amlodipine, nifedipine are oral formulations that are used in routine hypertension management. Nebivolol and\u00a0carvedilol are taken orally to treat hypertension.", "contents": "Vasodilators -- Administration. Calcium channel blockers such as clevidipine and nicardipine can be used intravenously in hypertensive emergencies while amlodipine, nifedipine are oral formulations that are used in routine hypertension management. Nebivolol and\u00a0carvedilol are taken orally to treat hypertension."}
{"id": "article-43010_17", "title": "Vasodilators -- Adverse Effects", "content": "ACE Inhibitors: angioedema, dry cough (due to increased bradykinin levels), teratogenicity, hyperkalemia, and hypotension. [7] There have been studies that show that the use of ACE inhibitors can increase a patient's risk of developing acute pancreatitis. [8] Examples: enalapril, lisinopril, captopril, ramipril. Angiotensin Receptor Blockers: hyperkalemia, hypotension, decrease GFR, teratogenicity. [9] Examples:\u00a0valsartan, losartan, candesartan.", "contents": "Vasodilators -- Adverse Effects. ACE Inhibitors: angioedema, dry cough (due to increased bradykinin levels), teratogenicity, hyperkalemia, and hypotension. [7] There have been studies that show that the use of ACE inhibitors can increase a patient's risk of developing acute pancreatitis. [8] Examples: enalapril, lisinopril, captopril, ramipril. Angiotensin Receptor Blockers: hyperkalemia, hypotension, decrease GFR, teratogenicity. [9] Examples:\u00a0valsartan, losartan, candesartan."}
{"id": "article-43010_18", "title": "Vasodilators -- Adverse Effects", "content": "Calcium Channel Blockers: gingival hyperplasia, dizziness, flushing, peripheral edema,\u00a0AV block (with Non-dihydropyridines), constipation. [10] Examples: Dihydropyridines: amlodipine, clevidipine, nicardipine, nifedipine;\u00a0Non-dihydropyridines: diltiazem and verapamil", "contents": "Vasodilators -- Adverse Effects. Calcium Channel Blockers: gingival hyperplasia, dizziness, flushing, peripheral edema,\u00a0AV block (with Non-dihydropyridines), constipation. [10] Examples: Dihydropyridines: amlodipine, clevidipine, nicardipine, nifedipine;\u00a0Non-dihydropyridines: diltiazem and verapamil"}
{"id": "article-43010_19", "title": "Vasodilators -- Adverse Effects", "content": "Nitrates: reflex tachycardia, headache, flushing, and orthostatic hypotension. [11] Examples: nitroglycerin, isosorbide mononitrate, isosorbide dinitrate.\u00a0Cyanide\u00a0toxicity\u00a0does not occur with intravenous use, but methemoglobinemia can occur. Hydralazine: compensatory tachycardia, headache, angina, SLE-like symptoms (in slow acetylators), fluid retention.", "contents": "Vasodilators -- Adverse Effects. Nitrates: reflex tachycardia, headache, flushing, and orthostatic hypotension. [11] Examples: nitroglycerin, isosorbide mononitrate, isosorbide dinitrate.\u00a0Cyanide\u00a0toxicity\u00a0does not occur with intravenous use, but methemoglobinemia can occur. Hydralazine: compensatory tachycardia, headache, angina, SLE-like symptoms (in slow acetylators), fluid retention."}
{"id": "article-43010_20", "title": "Vasodilators -- Adverse Effects", "content": "Nitroprusside: Nitroprusside is metabolized to cyanide,\u00a0and it can lead to cyanide toxicity. Toxicity can appear as little as four hours after initiation of infusion.\u00a0Potential risk factors for the development of toxicity are\u00a0underlying renal impairment,\u00a0prolonged treatment period (over 48 hours), and the utilization of a higher dose. [12] Minoxidil: hypertrichosis, water retention,\u00a0pericarditis that may progress to tamponade. Beta-Blockers: bradycardia, dizziness, headaches, nausea, hypotension, metabolic abnormalities.", "contents": "Vasodilators -- Adverse Effects. Nitroprusside: Nitroprusside is metabolized to cyanide,\u00a0and it can lead to cyanide toxicity. Toxicity can appear as little as four hours after initiation of infusion.\u00a0Potential risk factors for the development of toxicity are\u00a0underlying renal impairment,\u00a0prolonged treatment period (over 48 hours), and the utilization of a higher dose. [12] Minoxidil: hypertrichosis, water retention,\u00a0pericarditis that may progress to tamponade. Beta-Blockers: bradycardia, dizziness, headaches, nausea, hypotension, metabolic abnormalities."}
{"id": "article-43010_21", "title": "Vasodilators -- Adverse Effects", "content": "Americal Heart Association/American Stroke Association recommends not reducing blood pressure during the initial 24 hours of ischemic stroke unless it is over 220/120 mm Hg to prevent the worsening of ischemic injury. In the patient with ischemic stroke, BP requires lowering to less than 180/110 mm Hg before administering alteplase with intravenous labetalol/nicardipine.", "contents": "Vasodilators -- Adverse Effects. Americal Heart Association/American Stroke Association recommends not reducing blood pressure during the initial 24 hours of ischemic stroke unless it is over 220/120 mm Hg to prevent the worsening of ischemic injury. In the patient with ischemic stroke, BP requires lowering to less than 180/110 mm Hg before administering alteplase with intravenous labetalol/nicardipine."}
{"id": "article-43010_22", "title": "Vasodilators -- Contraindications", "content": "ACE Inhibitors: pregnancy, previous history of angioedema, hereditary angioedema. ARBs: ARBs\u00a0are teratogens and should\u00a0not be used in pregnant patients. Nitrates: Nitrates decrease preload, so the administration of nitrates would be contraindicated in a person having an inferior MI (right ventricular infarction). Calcium Channel Blocker : severe hypotension, hypersensitivity. Hydralazine: CAD or angina (it\u00a0can cause compensatory tachycardia), mitral valve rheumatic heart disease Beta-blockers: Bradycardia, severe chronic obstructive pulmonary disease, hypotension, cardiogenic shock, and high degree of atrioventricular block.", "contents": "Vasodilators -- Contraindications. ACE Inhibitors: pregnancy, previous history of angioedema, hereditary angioedema. ARBs: ARBs\u00a0are teratogens and should\u00a0not be used in pregnant patients. Nitrates: Nitrates decrease preload, so the administration of nitrates would be contraindicated in a person having an inferior MI (right ventricular infarction). Calcium Channel Blocker : severe hypotension, hypersensitivity. Hydralazine: CAD or angina (it\u00a0can cause compensatory tachycardia), mitral valve rheumatic heart disease Beta-blockers: Bradycardia, severe chronic obstructive pulmonary disease, hypotension, cardiogenic shock, and high degree of atrioventricular block."}
{"id": "article-43010_23", "title": "Vasodilators -- Monitoring", "content": "Vasodilators can be monitored by checking the blood levels of certain drugs. Microvascular monitoring is another way to detect therapeutic levels in patients who are taking vasodilators. [13] Microvascular\u00a0monitoring is the subject of many clinical trials and targets patients before and after vasodilator therapy as a way to detect hemodynamic coherence.", "contents": "Vasodilators -- Monitoring. Vasodilators can be monitored by checking the blood levels of certain drugs. Microvascular monitoring is another way to detect therapeutic levels in patients who are taking vasodilators. [13] Microvascular\u00a0monitoring is the subject of many clinical trials and targets patients before and after vasodilator therapy as a way to detect hemodynamic coherence."}
{"id": "article-43010_24", "title": "Vasodilators -- Monitoring", "content": "After initiation of vasodilators,\u00a0blood pressure (both standing and sitting/supine), heart rate should be monitored. If\u00a0the patient is on hydralazine\u00a0and develops\u00a0lupus-like symptoms, check antinuclear antibody (ANA) titers and anti-histone antibody levels. Clinicians should also check renal function values after 2\u00a0to 3 weeks after initiation of\u00a0ACE Inhibitors and\u00a0ARBs. Signs/symptoms of pericardial effusion should require monitoring while patients are on minoxidil.", "contents": "Vasodilators -- Monitoring. After initiation of vasodilators,\u00a0blood pressure (both standing and sitting/supine), heart rate should be monitored. If\u00a0the patient is on hydralazine\u00a0and develops\u00a0lupus-like symptoms, check antinuclear antibody (ANA) titers and anti-histone antibody levels. Clinicians should also check renal function values after 2\u00a0to 3 weeks after initiation of\u00a0ACE Inhibitors and\u00a0ARBs. Signs/symptoms of pericardial effusion should require monitoring while patients are on minoxidil."}
{"id": "article-43010_25", "title": "Vasodilators -- Toxicity", "content": "ACE Inhibitors: There are few documented cases of ACE inhibitor overdose. [14] One case report stated that treating\u00a0a patient who overdosed on lisinopril with hemodialysis worked. [15] In general, supportive care should be established in every case (IV fluids, vasopressors in case of severe hypotension). ARBs: Very few cases of ARB overdoses have been reported. [16] Treating overdose of this medication like any other drug intoxication is recommended. Calcium Channel Blocker : There is not much evidence on reversing the toxicity of CCBs. One study showed that high-dose insulin and life support were most effective in reversing toxicity. [17] Nitroprusside: Sodium thiosulfate is indicated in\u00a0the\u00a0patient who has cyanide toxicity. It provides sulfur, which converts cyanide into thiocyanate and prevents further adverse effects. Hydralazine,\u00a0Nitrates: Very few reported cases of overdose exist to date. Recommendations are to treat these overdoses like any other drug overdose.", "contents": "Vasodilators -- Toxicity. ACE Inhibitors: There are few documented cases of ACE inhibitor overdose. [14] One case report stated that treating\u00a0a patient who overdosed on lisinopril with hemodialysis worked. [15] In general, supportive care should be established in every case (IV fluids, vasopressors in case of severe hypotension). ARBs: Very few cases of ARB overdoses have been reported. [16] Treating overdose of this medication like any other drug intoxication is recommended. Calcium Channel Blocker : There is not much evidence on reversing the toxicity of CCBs. One study showed that high-dose insulin and life support were most effective in reversing toxicity. [17] Nitroprusside: Sodium thiosulfate is indicated in\u00a0the\u00a0patient who has cyanide toxicity. It provides sulfur, which converts cyanide into thiocyanate and prevents further adverse effects. Hydralazine,\u00a0Nitrates: Very few reported cases of overdose exist to date. Recommendations are to treat these overdoses like any other drug overdose."}
{"id": "article-43010_26", "title": "Vasodilators -- Toxicity", "content": "Beta-Blockers: Glucagon, sodium bicarbonate, and or magnesium may be used.", "contents": "Vasodilators -- Toxicity. Beta-Blockers: Glucagon, sodium bicarbonate, and or magnesium may be used."}
{"id": "article-43010_27", "title": "Vasodilators -- Enhancing Healthcare Team Outcomes", "content": "Clinicians need to educate their patients\u00a0about\u00a0the use of vasodilators. As described above, many adverse side effects exist with vasodilator treatment.\u00a0It is the healthcare provider's responsibility to make sure the patient understands the importance of taking their vasodilator medication as prescribed. Undertreatment and/or non-compliance can cause severe hypertension, and this can lead to catastrophic events such as stroke, hypertensive emergency, aortic dissection, and many other preventable diseases.\u00a0Also, it is crucial to educate patients\u00a0regarding healthy lifestyle habits and dietary modifications. Regular exercise, a healthy and well-balanced diet, and healthy lifestyle\u00a0habits (such as\u00a0avoidance of\u00a0smoking, excessive drinking, or using recreational drugs) can all help a patient's longevity. Nursing will often administer these drugs and need to be familiar with monitoring treatment progress as well as checking on adverse events, reporting any concerns to the clinician. Pharmacists, particularly board-certified cardiology pharmacists, can assist the clinician in agent selection as well as dosing, medication reconciliation, and patient education. These types of interprofessional team actions will improve outcomes with vasodilator therapy. [Level 5]", "contents": "Vasodilators -- Enhancing Healthcare Team Outcomes. Clinicians need to educate their patients\u00a0about\u00a0the use of vasodilators. As described above, many adverse side effects exist with vasodilator treatment.\u00a0It is the healthcare provider's responsibility to make sure the patient understands the importance of taking their vasodilator medication as prescribed. Undertreatment and/or non-compliance can cause severe hypertension, and this can lead to catastrophic events such as stroke, hypertensive emergency, aortic dissection, and many other preventable diseases.\u00a0Also, it is crucial to educate patients\u00a0regarding healthy lifestyle habits and dietary modifications. Regular exercise, a healthy and well-balanced diet, and healthy lifestyle\u00a0habits (such as\u00a0avoidance of\u00a0smoking, excessive drinking, or using recreational drugs) can all help a patient's longevity. Nursing will often administer these drugs and need to be familiar with monitoring treatment progress as well as checking on adverse events, reporting any concerns to the clinician. Pharmacists, particularly board-certified cardiology pharmacists, can assist the clinician in agent selection as well as dosing, medication reconciliation, and patient education. These types of interprofessional team actions will improve outcomes with vasodilator therapy. [Level 5]"}
{"id": "article-43010_28", "title": "Vasodilators -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Vasodilators -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}